Every 8-K that JBT Marel Corporation (JBTM) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow JBTM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full JBTM filings page.
JBT Marel Corporation reported solid second‑quarter 2026 results, with revenue of $981 million, up 5 percent, and orders above $1 billion, producing a 1.05x book‑to‑bill ratio. Net income was $28 million, a $25 million increase, for a 2.9 percent margin despite a $33 million non‑cash impairment charge related to a 2021 acquisition.
Adjusted EBITDA rose to $168 million with a 17.1 percent margin, and diluted EPS was $0.54 while adjusted EPS reached $1.95. The Protein Solutions segment grew revenue 11 percent with a 24.0 percent adjusted EBITDA margin, while Prepared Food and Beverage Solutions revenue was flat and margin slipped to 17.5 percent amid logistics constraints and productivity inefficiencies.
Year‑to‑date operating cash flow was $221 million and free cash flow $179 million. Net debt was $1,586 million, equating to 2.47x net debt to trailing twelve months adjusted EBITDA. The company repurchased about 200,000 shares for $26 million and reaffirmed full‑year 2026 guidance for $3,990–$4,065 million in revenue, 17.0–17.5 percent adjusted EBITDA margin, and adjusted EPS of $7.85–$8.35.
JBT Marel Corporation reported the results of its annual meeting of stockholders. A total of 46,668,495 shares of common stock were represented, constituting a quorum. Stockholders elected ten directors to serve until the 2027 annual meeting, with each nominee receiving substantially more votes "for" than "against."
Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers, with 42,078,943 votes for, 3,116,022 against, and 332,884 abstentions, plus 1,140,646 broker non-votes. In addition, they ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026, with 46,589,275 votes for, 25,979 against, and 53,241 abstentions.
JBT Marel Corporation filed an amended report to correct the start date of its previously announced share repurchase program. The program, authorized for up to $200 million of common stock, will now run from May 18, 2026 through May 31, 2029.
The company also declared a quarterly cash dividend of $0.10 per share of common stock, payable on June 9, 2026 to stockholders of record as of May 26, 2026. A press release detailing the corrected effective date and these capital return actions is included as an exhibit.
JBT Marel Corporation announced that its board has declared a quarterly cash dividend of $0.10 per share of outstanding common stock. The dividend will be paid on June 9, 2026, to stockholders of record as of May 26, 2026.
The board also authorized a new share repurchase program for up to $200 million of the company’s common stock, effective from June 1, 2026 through May 31, 2029. Repurchased shares will become treasury stock, and the company can modify, suspend, or discontinue the program at its discretion.
JBT Marel Corporation reported strong first quarter 2026 results and reiterated its full-year 2026 outlook. Revenue rose 10% to $936 million, with orders above $1 billion and a book-to-bill ratio of 1.14x. Net income was $45 million, reversing a $173 million loss a year earlier, and diluted EPS was $0.86 versus a $3.35 loss. Adjusted EPS increased to $1.58 from $0.97, and adjusted EBITDA grew to $142 million, a 15.2% margin. Free cash flow reached $100 million, reducing net debt to trailing twelve months adjusted EBITDA to 2.6x. Protein Solutions drove growth with 22% higher revenue and a 21.7% adjusted EBITDA margin, while Prepared Food and Beverage Solutions revenue was flat and margin softened. For full year 2026, the company continues to guide revenue of $3.99–$4.07 billion, net income margin of 6.1%–6.6%, adjusted EBITDA margin of 17.0%–17.5%, GAAP diluted EPS of $4.70–$5.15, and adjusted EPS of $8.00–$8.50, including anticipated restructuring, M&A, and acquisition-related amortization costs.
JBT Marel Corporation is using its 2026 Investor Day to lay out a long‑term growth and margin story after the JBT–Marel combination. Management highlights 2025 revenue of $3.8B with an Adjusted EBITDA margin of 15.8%, split between Protein Solutions and Prepared Food and Beverage Solutions.
The company targets organic revenue growth of 5–7% annually through 2028, driven by secular food and beverage demand, cross‑selling and integrated line solutions. It aims to lift Adjusted EBITDA margin to 20%, generate free cash flow equal to 55–60% of Adjusted EBITDA, realize about $150M of annual run‑rate cost synergies by 2027, and operate with leverage in the 2.0–2.5% range of net debt to Adjusted EBITDA.
JBT Marel Corporation reported strong top-line growth for 2025 while absorbing large integration and pension charges. Revenue from continuing operations reached $3.8 billion, with about 50% from recurring revenue, and full-year adjusted EBITDA was $600.4 million, a 15.8% margin. GAAP loss from continuing operations was $49.7 million, or $0.96 per diluted share, driven by $179 million of acquisition-related amortization and depreciation, $147 million of non-cash U.S. pension settlement charges, $114.5 million of M&A costs, and $30.7 million of restructuring costs. Orders were about $3.8 billion with year-end backlog of $1.372 billion, and free cash flow was $249.8 million. Net debt to trailing twelve-month adjusted EBITDA was 2.9x. For 2026, the company guides revenue to $3.99–$4.07 billion, income from continuing operations margin of 6.1–6.6%, adjusted EBITDA margin of 17.0–17.5%, GAAP EPS of $4.70–$5.15, and adjusted EPS of $8.00–$8.50.
JBT Marel Corporation has realigned its reporting structure to reflect integration after its January 2, 2025 acquisition of Marel hf. Effective in the fourth quarter of 2025, the company now reports two segments: Protein Solutions and Prepared Food and Beverage Solutions.
The chief executive officer now reviews results under this new structure, and historical segment data have been recast. Exhibit 99.1 provides segment revenue and Segment Adjusted EBITDA for the quarters ended March 31, June 30 and September 30, 2025 and for the years ended December 31, 2024 and 2023. The company states these changes do not affect previously reported consolidated net revenue, net earnings, earnings per share or total assets.
JBT Marel Corporation furnished an 8-K announcing it issued a press release with financial results for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The information under Item 2.02 is furnished, not filed, and is not subject to Section 18 liabilities; it will not be incorporated by reference into other filings except as expressly stated. The company’s common stock trades on the NYSE under the symbol JBTM.
JBT Marel Corporation announced the resignation of Vice President, Corporate Controller and Chief Accounting Officer, Jessi L. Corcoran, effective November 4, 2025. The company stated her departure follows acceptance of a role at another company and is not due to any disagreement regarding operations, policies, accounting principles, financial disclosures, or internal controls.
The Board designated Executive Vice President and Chief Financial Officer Matthew J. Meister to serve as principal accounting officer effective upon Ms. Corcoran’s departure. The company noted no additional compensation for Mr. Meister related to this designation and disclosed no related-party arrangements.
JBT Marel Corporation filed an 8-K reporting a material financing event tied to a convertible note offering and related hedging instruments. The filing attaches an Indenture dated September 9, 2025, the form of a 0.375% Convertible Senior Note due 2030, and confirmations for a bond hedge and warrants. The company also included a press release announcing the pricing of the offering dated September 4, 2025 and an interactive Cover Page XBRL file.
The documents indicate the company completed the legal and disclosure steps for the offering and associated derivatives (bond hedge and warrant confirmations). Signatory information shows Matthew J. Meister signed as Executive Vice President and Chief Financial Officer. The filing does not disclose the offering size, proceeds, or use of proceeds within the provided text.
JBT Marel Corporation filed an 8-K reporting several exhibits related to the Marel transaction. The filing includes a Second Amendment to the Second Amended and Restated Credit Agreement dated September 3, 2025, a press release announcing the launch of the Offering dated the same day, and unaudited pro forma condensed combined financial information reflecting the Marel Transaction, including a pro forma statement of income for the year ended December 31, 2024 and accompanying notes. Management’s Discussion and Analysis for Marel and an Inline XBRL cover page interactive data file are also furnished. The filing is signed by Matthew J. Meister.